Newsroom
Keep in touch
Join our mailing list to receive new information relating to biomarker discovery and detection.
Exazym®: New Detection Limits Open New Possibilities
26/09/2024Exazym® — Pixels to Proteins
26/09/2024Exazym® — Ultra-Sensitivity Meets Practicality
26/09/2024Exazym® — A Breakthrough in Precision Health
26/09/2024Cavidi supports Diagnostics Access Initiative
12/08/2014Cavidi strongly supports the Diagnostics Access Initiative (DAI)...
Continue readingCavidi in Swedish TECH20 - top 2% of start ups
04/06/2014The TECH20 winners have been announced - the 20 most c...
Continue readingInvestment with Impact: Closing the HIV treatment gap
09/05/2014I was pleased to speak at the United Nations this week as part o...
Continue readingCavidi Selected to Present at Cavendish Global Health Impact Forum
11/04/2014Stockholm 11th April 2014 — Cavidi, a specialis...
Continue readingWorld Aids Day 2013: Halfway to Zero
28/11/2013Each year World Aids Day helps raise awareness around the world....
Continue readingCavidi and Burnet Institute sign CD4 license agreement
15/11/2013Leading Swedish HIV diagnostic company Cavidi today an...
Continue readingCavidi joins UIC Business Accelerator
06/09/2013Cavidi, leading Swedish HIV companion diagnostic supplier, joins...
Continue readingViral load monitoring enters the mainstream
10/07/2013Last night I attended a dinner in Stockholm hosted by the Swedis...
Continue reading